Correlation Between Purple Biotech and Phio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on Purple Biotech and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Phio Pharmaceuticals.
Diversification Opportunities for Purple Biotech and Phio Pharmaceuticals
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Purple and Phio is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of Purple Biotech i.e., Purple Biotech and Phio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Purple Biotech and Phio Pharmaceuticals
Given the investment horizon of 90 days Purple Biotech is expected to generate 1.36 times more return on investment than Phio Pharmaceuticals. However, Purple Biotech is 1.36 times more volatile than Phio Pharmaceuticals Corp. It trades about -0.03 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about -0.13 per unit of risk. If you would invest 307.00 in Purple Biotech on August 28, 2024 and sell it today you would lose (33.00) from holding Purple Biotech or give up 10.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Purple Biotech vs. Phio Pharmaceuticals Corp
Performance |
| Timeline |
| Purple Biotech |
| Phio Pharmaceuticals Corp |
Purple Biotech and Phio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Purple Biotech and Phio Pharmaceuticals
The main advantage of trading using opposite Purple Biotech and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |